ONCOLYTICS BIOTECH Trademark

Trademark Overview

On Thursday, April 17, 2014, a trademark application was filed for ONCOLYTICS BIOTECH with the United States Patent and Trademark Office. The USPTO has given the ONCOLYTICS BIOTECH trademark a serial number of 86255705. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, November 3, 2021. This trademark is owned by Oncolytics Biotech Inc.. The ONCOLYTICS BIOTECH trademark is filed in the Pharmaceutical Products category with the following description:

Housemark for pharmaceutical products; pharmaceutical preparations for use in the treatment of cancer
oncolytics biotech

General Information

Serial Number86255705
Word MarkONCOLYTICS BIOTECH
Filing DateThursday, April 17, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, November 3, 2021
Registration Number4784261
Registration DateTuesday, August 4, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 19, 2015

Trademark Statements

Goods and ServicesHousemark for pharmaceutical products; pharmaceutical preparations for use in the treatment of cancer
NOT AVAILABLE"BIOTECH"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 2, 2014
Primary Code005
First Use Anywhere DateFriday, July 21, 2000
First Use In Commerce DateMonday, November 14, 2005

Trademark Owner History

Party NameOncolytics Biotech Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCalgary, Alberta T2R 0C5
CA
Party NameOncolytics Biotech Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCalgary, Alberta T2N1X7
CA
Party NameOncolytics Biotech Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCalgary, Alberta T2N1X7
CA

Trademark Events

Event DateEvent Description
Friday, May 2, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 21, 2014NEW APPLICATION ENTERED
Friday, September 12, 2014PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, July 28, 2014ASSIGNED TO EXAMINER
Monday, July 28, 2014EXAMINERS AMENDMENT -WRITTEN
Monday, July 28, 2014EXAMINERS AMENDMENT E-MAILED
Monday, July 28, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 28, 2014EXAMINER'S AMENDMENT ENTERED
Monday, July 28, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 5, 2014ASSIGNED TO LIE
Saturday, August 9, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 26, 2014WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, March 23, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 27, 2014NON-FINAL ACTION WRITTEN
Monday, October 27, 2014NON-FINAL ACTION E-MAILED
Monday, October 27, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 23, 2015EXAMINERS AMENDMENT -WRITTEN
Monday, March 23, 2015EXAMINERS AMENDMENT E-MAILED
Monday, March 23, 2015EXAMINER'S AMENDMENT ENTERED
Monday, March 23, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 11, 2015ASSIGNED TO LIE
Saturday, April 11, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 29, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 19, 2015PUBLISHED FOR OPPOSITION
Tuesday, May 19, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 4, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, August 4, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, July 28, 2021TEAS SECTION 8 & 15 RECEIVED
Wednesday, November 3, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 3, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, August 4, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, November 3, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Related Keywords

biotech oncolytics pharmaceutical cancer treatment products housemark preparations